Back to Journals » OncoTargets and Therapy » Volume 9

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma

Total article views   Abstract views HTML views PDF downloads Totals
5,102 Dovepress* 3,755 670+ 1,019 4,425
PubMed Central* 0 677 276 677
Totals 3,755 1,347 1,295 5,102
*Since 15 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar